Merck Strikes Teva With 3rd Singulair Suit
A Merck & Co. affiliate has filed a third lawsuit over its blockbuster allergy and asthma drug Singulair against Teva Pharmaceuticals USA Inc....To view the full article, register now.
Already a subscriber? Click here to view full article